Status:

COMPLETED

A Study of TAK-441 in Adult Patients With Advanced Nonhematologic Malignancies

Lead Sponsor:

Millennium Pharmaceuticals, Inc.

Conditions:

Advanced Nonhematologic Malignancies

Carcinoma, Basal Cell

Eligibility:

All Genders

18+ years

Phase:

PHASE1

Brief Summary

This is the first study in which TAK-441 is administered to humans. The patient population will consist of adults aged 18 or older who have advanced nonhematologic malignancies and for whom standard t...

Eligibility Criteria

Inclusion

  • Each patient must meet all of the following inclusion criteria to be enrolled in the study:
  • Male or female 18 years or older
  • Eastern Cooperative Oncology Group (ECOG) performance status 0 to 2
  • Diagnosis of a nonhematologic malignancy for which standard treatment is no longer effective or does not offer curative or life-prolonging potential
  • Meet other clinical, radiographic or laboratory inclusion criteria as specified in the protocol
  • Voluntary written consent

Exclusion

  • Patients meeting any of the following exclusion criteria are not to be enrolled in the study:
  • Life-threatening illness unrelated to cancer
  • Receiving other treatment (radiotherapy, antineoplastics or investigational agents) within protocol specified windows of first dose of TAK-441
  • Patients with brain metastases who do not meet criteria specified in study protocol
  • Known history of human immunodeficiency virus (HIV) infection, hepatitis B or hepatitis C
  • Major surgery within 14 days before the first dose of TAK-441
  • Infection requiring systemic therapy, or other serious infection within 14 days of the first dose of TAK-441
  • Do not meet other clinical, laboratory or radiographic criteria as specified in the protocol

Key Trial Info

Start Date :

October 1 2010

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

January 1 2013

Estimated Enrollment :

34 Patients enrolled

Trial Details

Trial ID

NCT01204073

Start Date

October 1 2010

End Date

January 1 2013

Last Update

July 2 2013

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Mayo Clinic

Scottsdale, Arizona, United States, 85259-5499

2

Premiere Oncology, A Medical Corporation

Santa Monica, California, United States, 90404